The self-administered psoriasis area and severity index is valid and reliable

被引:227
作者
Feldman, SR
Fleischer, AB
Reboussin, DM
Rapp, SR
Exum, ML
Clark, AR
Nurre, L
机构
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PATHOL,WINSTON SALEM,NC 27157
[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PUBL HLTH SCI,WINSTON SALEM,NC 27157
[3] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PSYCHIAT & BEHAV MED,WINSTON SALEM,NC 27157
关键词
PASI; epidemiology; validity;
D O I
10.1111/1523-1747.ep12329912
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The self-administered psoriasis area and severity index (SAPASI) is a structured instrument for measuring the severity of psoriasis. This study examines the validity, reliability, and responsiveness of the SAPASI, Trained personnel performed a psoriasis area and severity index (PASI) assessment on the same day a SAPASI was obtained from 80 subjects. The validity of the SAPASI was demonstrated using the PASI as the standard (r(2) = 0.59, p = 0.0001). Significant correlations were found between SAPASI and PASI for body surface area (r = 0.62-0.75), erythema (r = 0.39), induration (r = 0.24) and scale (r = 0.38). Test-retest reliability was assessed in 19 subjects with repeated evaluations within 2 d, Correlations between the first and second SAPASI scores (r = 0.82) were highly significant (p = 0.0001), Inter-rater reliability of SAPASI body surface area measurements among five raters was very high (intraclass correlation coefficient R = 0.953). The SAPASI was responsive to changes in severity over time as demonstrated by correlation with changes in PASI scores (r 0.63, p = 0.0002), We conclude that this structured patient self-report instrument facilitates quantitative assessment of psoriasis.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 13 条
[1]   RELATION BETWEEN URINARY ALBUMIN EXCRETION AND SKIN INVOLVEMENT IN PATIENTS WITH PSORIASIS [J].
CECCHI, R ;
SEGHIERI, G ;
GIRONI, A ;
TUCI, F ;
GIOMI, A .
DERMATOLOGY, 1992, 185 (02) :93-95
[2]  
COLLINS P, 1992, BRIT J DERMATOL, V127, P392
[3]   PATIENT MEASUREMENT OF PSORIASIS DISEASE SEVERITY WITH A STRUCTURED INSTRUMENT [J].
FLEISCHER, AB ;
RAPP, SR ;
REBOUSSIN, DM ;
VANARTHOS, JC ;
FELDMAN, SR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :967-969
[4]  
Fleiss J. L., 1999, The Design and Analysis of Clinical Experiments, DOI [DOI 10.1002/9781118032923, 10.1002/9781118032923]
[5]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[6]   FEELINGS OF STIGMATIZATION IN PATIENTS WITH PSORIASIS [J].
GINSBURG, IH ;
LINK, BG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (01) :53-63
[7]   INCREASED URINE NEOPTERIN LEVELS IN PSORIASIS [J].
HARLAND, CC ;
WHITAKER, RP ;
BARRON, JL ;
HOLDEN, CA .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (05) :453-457
[8]   PSYCHOMETRIC CONSIDERATIONS IN EVALUATING HEALTH-RELATED QUALITY-OF-LIFE MEASURES [J].
HAYS, RD ;
ANDERSON, R ;
REVICKI, D .
QUALITY OF LIFE RESEARCH, 1993, 2 (06) :441-449
[9]   A DOUBLE-BLIND COMPARISON OF ACITRETIN AND ETRETINATE IN COMBINATION WITH BATH PUVA IN THE TREATMENT OF EXTENSIVE PSORIASIS [J].
LAUHARANTA, J ;
GEIGER, JM .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (01) :107-112
[10]   ASSESSMENT OF DISEASE PROGRESS IN PSORIASIS [J].
MARKS, R ;
BARTON, SP ;
SHUTTLEWORTH, D ;
FINLAY, AY .
ARCHIVES OF DERMATOLOGY, 1989, 125 (02) :235-240